HBV progress towards coverage targets.https://cdafound.org/polaris-countries-dashboard/Accessed: January 2023. [8]Terrault N A, Lok A S F, McMahon B J, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance[J]. Hepatology, 2018, ...
[7]Polaris Observatory Collaborators. HBV progress towards coverage targets.https://cdafound.org/polaris-countries-dashboard/Accessed: January 2023. [8]Terrault N A, Lok A S F, McMahon B J, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B...
2 The WHO also set a global target for treatment coverage in people with chronic HBV infection eligible for antiviral therapy from 8% (2015) to 80% (2030).3 To scale up and decentralize screening, clinical assessment and treatment services in LMICs, it is essential to develop simple and ...
This review discusses recent developments and challenges facing the field of anti-HBV gene therapy, its potential curative significance and the progress towards clinical application. Keywords: hepatitis B virus; covalently closed circular DNA; gene therapy; epigenetic modification; designer nucleases 1. ...
This review discusses recent developments and challenges facing the field of anti-HBV gene therapy, its potential curative significance and the progress towards clinical application. Keywords: hepatitis B virus; covalently closed circular DNA; gene therapy; epigenetic modification; designer nucleases...